Navigation Links
Analog thermal printer, Mitsubishi (115/230V) for BioDoc-It and VisiDoc-It Imaging Systems from UVP

ProductsAnalog thermal printer, Mitsubishi (115/230V) for BioDoc-It and VisiDoc-It Imaging Systems from UVP
Company UVP
Item Analog thermal printer, Mitsubishi (115/230V) for BioDoc-It and VisiDoc-It Imaging Systems
Price 
Description Conveniently document gels, films and membranes with a high quality thermal printer.
  • Compact, footprint printer
  • Supplies 256 gray scale for high resolution, archive-quality thermal film prints
  • Process low-cost prints in seconds
Info UVPUVP
UVP, Inc.
2066 W. 11th Street
Upland, CA 91786
USA

Call UVP to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-290-5789
Customer Service:
US: (800)452-6788
UK / Europe: +44(0)1223-420022
Fax Number: (909)946-3597
Web Site: http://www.uvp.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. RNA Cap Analog, Trimethylated from EPICENTRE Biotechnologies
2. RNA Cap Analog, Unmethylated from EPICENTRE Biotechnologies
3. RNA Cap Analog, Methylated from EPICENTRE Biotechnologies
4. ARCA (Anti Reverse Cap Analog) from Ambion
5. m7G(5)ppp(5)G (Cap Analog) from Ambion
6. m7G(5)ppp(5)G (Cap Analog) from Ambion
7. Analog thermal printer, Mitsubishi (115V) for all UVP imaging systems except BioDoc-It and VisiDoc-It from UVP
8. Analog thermal printer, Sony (230V) for DigiDoc-It, MultiDoc-It and ChromaDoc-It Imaging Systems from UVP
9. ARCA (Anti Reverse Cap Analog) from Ambion
10. m7G(5)ppp(5)G (Cap Analog) from Ambion
11. Mastercycler ep gradient S thermal cycler from Eppendorf North America
... Kit Includes: Sufficient library for 10 ... 10^9 independent sequences, -28 gIII Sequencing ... sequencing, -96 gIII Sequencing Primer (100 ... E. coli strain ER2738, Control target ...
...
... library screening, optimal siRNA transfection ... verified for each cell type ... Transfection Optimization Kit, which was ... conditions in 96 well plates, ...
Applications: Western blotting ...
Biology Products:
(Date:1/22/2015)...  A man-made form of insulin delivered by nasal spray ... adults with mild cognitive impairment and Alzheimer,s disease dementia, ... Wake Forest Baptist Medical Center. The study,s ... impairment (MCI) or mild to moderate Alzheimer,s dementia (AD). ...
(Date:1/22/2015)... 21, 2015  Analyst Report Issued by Small Cap IR. In ... that planet-wide, transactions at merchants on the leading payment cards ... of credit, debit, and prepaid cards reached 6.54 billion.  Eight ... fraudulent card usage in 2012, and credit and debit card ...
(Date:1/22/2015)... , Jan. 22, 2015   EyeLock, Inc. , a ... has appointed Steve Gerber to the new role ... be responsible for leading development of mobile platforms and wearable ... of success and innovation in the semiconductor industry to his ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... team led by St. Jude Children,s Research Hospital scientists ... the childhood eye tumor retinoblastoma. Their work also settles ... are as scrambled as the developmental pathways at work ... a particular type of cell, researchers showed that retinoblastoma ...
... recent study suggests that parasites in fish, including threatened species ... fish health than has been assumed, and could be one ... changes cause salmon mortality. It,s not just the presence ... but their numbers that can build up over years or ...
... Extinction is a focal issue among scientists, policy makers ... are thought to have disappeared are rediscovered. Yet, these ... from the National University of Singapore (NUS), University of ... 122 years, at least 351 species which are thought ...
Cached Biology News:Childhood eye tumor made up of hybrid cells with jumbled development 2Childhood eye tumor made up of hybrid cells with jumbled development 3Parasite loads an underlying cause of salmon mortality, linked to land use changes 2Rediscovery of disappeared species: Truly back from the brink? 2
(Date:2/27/2015)... SUMMERLAND, British Columbia , Feb. 27, 2015 /PRNewswire/ ... a leader in synthetic biology, today announced it has ... (OSF), the pioneering agricultural company behind the ... apple. Through the acquisition, Intrexon expands its food programs ... and convenient for consumers while providing economic benefit throughout ...
(Date:2/27/2015)... , Feb. 27, 2015 A paper ... NCATS rare-diseases portfolio " in Science Translational ... financing technique to reduce the risk associated with ... potentially unlock new levels of funding for developing ... of a unique collaboration between scientists at the ...
(Date:2/27/2015)... 27, 2015 Immunovaccine Inc. (“Immunovaccine”) ... company, today announced that the U.S. Food and ... Track designation and Phase I clinical trials of ... the mutual co-development agreement signed with Gilead Life ... designation for the DPX-Survivac. , “We have been ...
(Date:2/27/2015)... 27, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY) is ... of BNC105 in patients with metastatic renal cancer at ... Florida . The data will be presented by ... Hope Comprehensive Cancer Center in California ... new data identifies Ferritin and IL-8 as two baseline ...
Breaking Biology Technology:Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5